Effect of monocyte chemoattractant protein‐1 (MCP‐1) gene polymorphism in Turkish patients with premature coronary artery disease

References

• Ergun M., Islegen C. Coronary heart disease's risk factors and exercise. J Card Res 2006; 2: 23–33
   Google Scholar
• Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med 1999; 340: 115–26
   PubMed Web of Science ®Google Scholar
• Adams D. H., Lloyd A. R. Chemokines: leucocyte recruitment and activation cytokines. Lancet 1997; 349: 490–5
   PubMed Web of Science ®Google Scholar
• Glass C. K., Witztum J. L. Atherosclerosis. The road ahead. Cell 2001; 104: 503–16
   PubMed Web of Science ®Google Scholar
• Yla‐Herttuala S., Lifton B., Rosenfeld M., Sarkioja T., Yoshimura, Leonard E. J., et al. Expression of MCP‐1 in macrophage‐rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 1991; 88: 5252–6
   PubMed Web of Science ®Google Scholar
• Nelken N., Coughlin S., Gordon D., Wilcox J. MCP‐1 in human atheromatous plaques. J Clin Invest 1991; 88: 1121–7
   PubMed Web of Science ®Google Scholar
• Yu X., Dluz S., Graves D. T., Zhang L., Antoniades H. N., Hollander W., et al. Elevated expression of MCP‐1 by vascular smooth muscle cells in hypercholesterolemic primates. Proc Natl Acad Sci USA 1992; 89: 6953–7
   PubMed Web of Science ®Google Scholar
• Kowala M., Recce R., Beyer S., Gu C., Valentine M. Characterization of atherosclerosis in LDL receptor knockout mice: macrophage accumulation correlates with rapid and sustained expression of aortic MCP‐1/JE. Atherosclerosis 2000; 149: 323–30
   PubMed Web of Science ®Google Scholar
• Takeya M., Yoshimura T., Leonard E. J., Takahashi K. Detection of monocyte chemoattractant protein‐1 in human atherosclerotic lesions by an anti‐monocyte chemoattractant protein‐1 monoclonal antibody. HumPathol 1993; 24: 534–9
   Google Scholar
• Deo R., Khera A., McGuire D. K., Murphy S. A., Neto J. P. M., Morrow D. A., et al. Association among plasma levels of monocyte chemoattractant protein‐1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J Am Coll Cardiol 2004; 44: 1812–18
   PubMed Web of Science ®Google Scholar
• Matsumori A., Furukawa Y., Hashimoto T., Yoshida A., Ono K., Shioi T., et al. Plasma levels of monocyte chemotactic and activating factor/monocyte chemoattractant protein‐1 are elevated in patients with acute myocardial infarction. J Mol Cell Cardiol 1997; 29: 419–23
   PubMed Web of Science ®Google Scholar
• Soejima H., Ogawa H., Yasue H., Kaikita K., Takazoe K., Nishiyama K., et al. Angiotensin‐converting enzyme inhibition reduces monocyte chemoattractant protein‐1 and tissue factor levels in patients with myocardial infarction. J Am Coll Cardiol 1999; 34: 983–8
   PubMed Web of Science ®Google Scholar
• Aukrust P., Berge R. K., Ueland T., Aaser E., Damas J. K., Wikeby L., et al. Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes. J Am Coll Cardiol 2001; 37: 485–91
   PubMed Web of Science ®Google Scholar
• Cipollone F., Marini M., Fazia M., Pini B., Iezzi A., Reale M., et al. Elevated circulating levels of monocyte chemoattractant protein‐1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol 2001; 21: 327–34
   PubMed Web of Science ®Google Scholar
• Oshima S., Ogawa H., Hokimoto S., Nakamura S., Noda K., Saito T., et al. Plasma monocyte chemoattractant protein‐1 antigen levels and the risk of restenosis after coronary stent implantation. Jpn Circ J 2001; 65: 261–4
   PubMedGoogle Scholar
• van Aken B. E., den Heijer M., Bos G. M., van Deventer S. J., Reitsma P. H. Recurrent venous thrombosis and markers of inflammation. Thromb Haemost 2000; 83: 536–9
   PubMed Web of Science ®Google Scholar
• Jibiki T., Terai M., Shima M., Ogawa A., Hamada H., Kanazawa M., et al. Monocyte chemoattractant protein 1 gene regulatory region polymorphism and serum levels of monocyte chemoattractant protein 1 in Japanese patients with Kawasaki disease. Arthritis Rheum 2001; 44: 2211–12
   PubMed Web of Science ®Google Scholar
• Rovin B., Lu L., Saxena R. A novel polymorphism in the MCP‐1 gene regulatory region that influences MCP‐1 expression. Biochem Biophys Res Commun 1999; 259: 344–8
   PubMed Web of Science ®Google Scholar
• McGlinchey P. G., Spence M. S., Patterson C. C., Allen A. R., Murphy G., Belton C., et al. Lack of association between the −2518G/A polymorphism of the MCP‐1 gene and ischaemic heart disease: a family‐based investigation. Tissue Antigens 2004; 64: 199–203
   PubMedGoogle Scholar
• Hwang S. Y., Cho M. L., Park B., Kim J. Y., Kim Y. H., Min D. J., et al. Allelic frequency of the MCP‐1 promoter −2518 polymorphism in the Korean population and in Korean patients with rheumatoid arthritis, systemic lupus erythematosus and adult‐onset Still's disease. Eur J Immunogenet 2002; 29: 413–16
   PubMedGoogle Scholar
• Szalai C., Kozma G. T., Nagy A., Bojszko A., Krikovszky D., Szabo, et al. Polymorphism in the gene regulatory region of MCP‐1 is associated with asthma susceptibility and severity. J Allergy Clin Immunol 2001; 108: 375–81
   PubMed Web of Science ®Google Scholar
• Szalai C., Duba J., Prohaszka Z., Kalina A., Szabo T., Nagy B., et al. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD): coincidence of elevated Lp(a) and MCP‐1 −2518 G/G genotype in CAD patients. Atherosclerosis 2001; 158: 233–9
   PubMed Web of Science ®Google Scholar
• Aguilar F., Gonzalez‐Escribano M. F., Sanchez‐Roman J., Nunez‐Roldan A. MCP‐1 promoter polymorphism in Spanish patients with systemic lupus erythematosus. Tissue Antigens 2001; 58: 335–8
   PubMedGoogle Scholar
• Ozyürek A. R., Gürses D., Ulger Z., Levent E., Bakiler A. R., Berdeli A. Allelic frequency of the MCP‐1 promoter −2518 polymorphism in the Turkish population and in Turkish patients with juvenile rheumatoid arthritis. Clin Rheumatol 2007; 26: 546–50
   PubMed Web of Science ®Google Scholar
• Simeoni E., Winkelmann B. R., Hoffmann M. M., Fleurya S., Ruize J., Kappenbergera L., et al. Association of RANTES G‐403A gene polymorphism with increased risk of coronary arteriosclerosis. Eur Heart J 2004; 25: 1438–46
   PubMed Web of Science ®Google Scholar
• Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Nomenclature and Criteria for Diagnosis of Ischemic Heart Disease. Circulation 1979; 59: 607–8
   PubMed Web of Science ®Google Scholar
• Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults – the evidence report. National Institutes of Health. Obes Res 1998; 6(Suppl 2)51S–209S
   PubMedGoogle Scholar
• Hirschhorn C. J., O'Donnell P. M., Murphy E. J., Benjamin M., Massaro J. F., Keaney Jr., et al. CCL2 polymorphisms are associated with serum monocyte chemoattractant protein‐1 levels and myocardial infarction in the Framingham Heart Study. Circulation 2005; 112: 1113–20
   PubMed Web of Science ®Google Scholar
• Alonso‐Villaverde C., Coll B., Parra S., Montero M., Calvo N., Tous M., et al. Atherosclerosis in patients infected with HIV is influenced by a mutant monocyte chemoattractant protein‐1 allele. Circulation 2004; 110: 2204–9
   PubMed Web of Science ®Google Scholar
• Yamada Y., Izawa H., Ichihara S., Takatsu F., Ishihara H., Hirayama H., et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002; 347: 1916–23
   PubMed Web of Science ®Google Scholar
• Bjarnadottir K., Eiriksdottir G., Aspelund T., Gudnason V. Examination of genetic effects of polymorphisms in the MCP‐1 and CCR2 genes on MI in the Icelandic population. Atherosclerosis 2006; 188: 341–6
   PubMed Web of Science ®Google Scholar
• Cermakova Z., Petrkova J., Arakelyan A., Drabek J., Mrazek F., Luk J., et al. The MCP‐1 −2518 (A to G) single nucleotide polymorphism is not associated with myocardial infarction in the Czech population. Intl J Immunogenet 2005; 32: 315–18
   PubMed Web of Science ®Google Scholar
• Pola R., Flex A., Gaetani E., Proia A. S., Papaleo P., Di Giorgio A., et al. Monocyte chemoattractant protein‐1 (MCP‐1) gene polymorphism and risk of Alzheimer's disease in Italians. Exp Gerontol 2004; 39: 1249–52
   PubMed Web of Science ®Google Scholar
• Tabara Y., Kohara K., Yamamoto Y., Igase M., Nakura J., Kondo I., et al. Polymorphism of the monocyte chemoattractant protein (MCP‐1) gene is associated with the plasma level of MCP‐1 but not with carotid intima‐media thickness. Hypertens Res 2003; 26: 677–83
   PubMed Web of Science ®Google Scholar